Larvol Delta - Circle-Pharma-les-rst-Investigational-New-Drug-application-for-rstinclass-oral-cyclin-AB-RxL-inhibitor-for-treatment-of-advanced-solid-tumors

CID-078 - Circle Pharma

https://www.businesswire.com/news/home/20240701057513/en/Circle-Pharma-files-first-Investigational-New-Drug-application-for-first-in-class-oral-cyclin-AB-RxL-inhibitor-for-treatment-of-advanced-solid-tumors

Jul 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next